CIK 0001551152
- Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320375147
- Phone
- +1 847-932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- 4 Grant or award EVP, CHIEF HR OFFICER acquired 79,252 shares (grant or award)
- 4 Grant or award VICE CHAIRMAN acquired 109,103 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, CHIEF HR OFFICER sold 42,370 shares at an average $163.44 ($6,925,018)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Vice Chairman sold 79,801 shares at an average $150.90 ($12,041,780)
- 4/A Open-market sale EVP, Chief Strategy Officer sold 83,960 shares at $155.00 ($13,013,800)
- 4/A Open-market sale EVP, Chief Strategy Officer sold 25,000 shares at an average $147.29 ($3,682,189)
- 4 Open-market sale Vice Chairman sold 200,000 shares at an average $154.25 ($30,849,488)
- 4 Open-market sale EVP, Chief Strategy Officer sold 83,960 shares at $155.00 ($13,013,800)
- 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 2,876 shares (to pay taxes)
- 4 Open-market sale Vice Chairman sold 300,000 shares at an average $151.12 ($45,336,288)
- 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 234 shares (to pay taxes)
- 4 Grant or award Director acquired 1,421 shares (grant or award)
Page 12 of 44 · 878 filings